Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.

• The therapeutic outcome of TACE varies greatly even for patients with the same clinicopathologic features. • Radiomics showed excellent performance in predicting the TACE response. • Decision curves demonstrated that the novel predictive model based on the radiomics signature and clinical indicators has great clinical utility.